Prime/boost HIV vaccine shows high immunogenicity in healthy volunteers in phase I/II trial Feb. 26, 2010
Phase II data support potential benefit of bevacizumab in HIV-associated Kaposi's sarcoma Feb. 26, 2010
HSP90 inhibitor STA-9090 targets oncogenic functions of Wilms tumor protein in AML cells Feb. 25, 2010
DIVA 01 trial data indicate good penetration of raltegravir in genital tract of HIV-infected women Feb. 25, 2010
RSS